MedTrace Logo

Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol?

NCT03472456 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-09-17

No results posted yet for this study

Summary

The objective of the study is to determine which of the two commonly used endodontic medications (Eugenol VS Articaine) is most effective in controlling postoperative pain in irreversible pulpitis of the mature permanent tooth in adults. To do so, an assessment of the pain felt by patients will be carried out a few days apart. The supposed results are that the medications are equivalent in terms of effectiveness on the pain, but could then present different economic arguments

Conditions

  • Pulpitides
  • Endodontic Inflammation
  • Toothaches
  • Operative Dentistry

Interventions

DRUG

Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne

Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne

DRUG

Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol

Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    lead OTHER

Principal Investigators

  • Damien OFFNER · Les Hôpitaux Universitaires de Strasbourg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-22
Primary Completion
2018-03-22
Completion
2019-10-24

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03472456 on ClinicalTrials.gov